Jean Claude Tardif
About Jean Claude Tardif
Jean Claude Tardif is a prominent Canadian cardiologist and researcher, currently serving as the Director of the Canada Research Chair in Translational and Personalized Medicine at the Government of Canada. He has extensive experience in academia and clinical practice, holding various positions at institutions such as the Montreal Heart Institute and Université de Montréal.
Work at Government of Canada
Jean Claude Tardif currently serves as the Director of the Canada Research Chair in Translational and Personalized Medicine at the Government of Canada. He has held this position since 2012, focusing on advancing research in personalized medicine. In addition, he has been the Director of the Canada Research Chair in Personalized Medicine since 2006. His work involves overseeing significant research initiatives aimed at improving health outcomes through personalized approaches.
Education and Expertise
Jean Claude Tardif has an extensive educational background in medicine. He obtained his Doctor of Medicine degree from Université de Montréal from 1982 to 1987. He completed various fellowships, including a Cardiology Research Fellowship at Tufts University School of Medicine from 1992 to 1994, and achieved Fellow status from the Royal College of Physicians and Surgeons of Canada in both Internal Medicine and Cardiology. His academic training has equipped him with a strong foundation in translational and personalized medicine.
Background
Jean Claude Tardif has a diverse professional background, having worked in various capacities in medical education and research. He served as a Resident Representative at Université de Montréal from 1991 to 1992 and later as an Instructor of Medicine at Tufts University School of Medicine from 1992 to 1994. He also held the position of Assistant Professor of Medicine at Université de Montréal from 1994 to 1999. His clinical practice as a cardiologist at the Montreal Heart Institute began in 1994, where he continues to work.
Achievements
Jean Claude Tardif is recognized for his contributions to the field of cardiology and personalized medicine. He is the founding father of Clementia Pharmaceuticals and serves as a founding scientific partner in DalCor. He chairs the steering committees for the Canadian Atherosclerosis Imaging Network (CAIN) and the Medical Imaging Trials Network of Canada (MITNEC), which are funded by the Canadian Institutes of Health Research (CIHR). Additionally, he is the Scientific Director of the Montreal Health Innovations Coordinating Centre (MHICC).